Down, but hardly out, at comeback-primed Chembio
By GREGORY ZELLER // Operating and net losses that more than tripled year-over-year tell only part of the story of Chembio Diagnostic Systems Inc.’s first quarter. That was the message…
HIV-1 virus
Before the cure, an HIV inhibitor?
By GREGORY ZELLER A cure for AIDS? Let’s not get ahead of ourselves. Few people understand the molecular world like Stony Brook prof Carol Carter, and the longtime researcher will tell…